Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Camerlinck Robert. Director active across 1 company, notably Cano Health, Inc.. Aggregated, 7 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €21k. Activity tracked since 11 August 2023. The latest transaction was disclosed on 11 August 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Robert Camerlinck is a declarant linked to Cano Health, Inc. (XNAS), where he is Chief Operating Officer. The record shows 7 filings in total, and across the 7 sampled filings there were no buys and EUR 21357 of sells, with publications ranging from 2022-08-12 to 2024-07-02.